Lifileucel (Clinical Applications)
• Metastatic Melanoma: Lifileucel is primarily used to treat metastatic melanoma, particularly in patients who have progressed after or are refractory to other treatments such as checkpoint inhibitors
(e.g., pembrolizumab, nivolumab) and
BRAF/MEK inhibitors